Remove Atherosclerosis Remove Coronary Artery Disease Remove Plaque
article thumbnail

How To Reverse Coronary Artery Disease With Lifestyle Measures

Dr. Paddy Barrett

Reversing or regressing coronary artery disease is possible. You cannot eliminate the plaque entirely, but multiple clinical trials have shown plaque regression using high-intensity cholesterol-lowering treatments, which I have discussed previously. REVERSAL Investigators. 2004 Mar 3;291(9):1071-80.

article thumbnail

Depression and Subclinical Coronary Atherosclerosis in Adults Without Clinical Coronary Artery Disease

Journal of the American Heart Association

BackgroundThe relationship between depression and subclinical coronary atherosclerosis in asymptomatic individuals is not clear. The degree and extent of subclinical coronary atherosclerosis were evaluated by coronary computed tomographic angiography, and ≥50% diameter stenosis was defined as significant.

article thumbnail

New 'atherosclerosis atlas' sheds light on heart attacks, strokes

Medical Xpress - Cardiology

University of Virginia School of Medicine researchers have created an "atlas of atherosclerosis" that reveals, at the level of individual cells, critical processes responsible for forming the harmful plaque buildup that causes heart attacks, strokes, and coronary artery disease.

article thumbnail

New 'Atherosclerosis Atlas' Sheds Light on Heart Attacks, Strokes

DAIC

MILLER, PHD, LED THE DEVELOPMENT OF A NEW "ATHEROSCLEROSIS ATLAS" THAT DETAILS, AT THE LEVEL OF INDIVIDUAL CELLS, CRITICAL PROCESSES RESPONSIBLE FOR FORMING THE HARMFUL PLAQUE BUILDUP THAT CAUSES HEART ATTACKS, STROKES AND CORONARY ARTERY DISEASE. THE UNIVERSITY OF VIRGINIA SCHOOL OF MEDICINE'S CLINT L.

article thumbnail

Biomechanical factors and atherosclerosis localization: insights and clinical applications

Frontiers in Cardiovascular Medicine

Although the entire vascular bed is constantly exposed to the same risk factors, atherosclerosis manifests a distinct intra-individual pattern in localization and progression within the arterial vascular bed.

article thumbnail

Abstract 4132968: CCR5 modulation enhances M-MDSCs functionality in early atherosclerosis

Circulation

CCR5, a chemokine receptor, has been associated with both immunosuppressive and inflammatory phenotypes, however, the possible role of CCR5 pertaining to MDSCs in the development of atherosclerosis has not been elucidated yet. Possibly this dysfunctionality contributes to the development and progression of CVD including atherosclerosis.

article thumbnail

Medicare Administrative Contractors to Extend Coverage of AI Coronary Plaque Analysis

DAIC

15, 2024 – Elucid has announced that four of the seven Medicare Administrative Contractors (MACs) will extend coverage for AI-enabled quantitative coronary plaque analysis, including its FDA-cleared PlaqueIQ image analysis software, beginning Nov. In the United States, one person dies every 33 seconds from cardiovascular disease.